175 related articles for article (PubMed ID: 25630554)
61. Cytochrome P450 1A1 gene polymorphisms and endometrial cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP; Choussein S; Vlahos NF
Int J Gynecol Cancer; 2011 Feb; 21(2):323-31. PubMed ID: 21270613
[TBL] [Abstract][Full Text] [Related]
62. Association between CYP1A1 polymorphisms and esophageal cancer: a meta-analysis.
Shen FF; Zhou FY; Xue QS; Pan Y; Zheng L; Zhang H; Wang LD; Zheng HF
Mol Biol Rep; 2013 Oct; 40(10):6035-42. PubMed ID: 24065535
[TBL] [Abstract][Full Text] [Related]
63. CYP1A1 gene polymorphism and risk of endometrial hyperplasia and endometrial carcinoma.
Esinler I; Aktas D; Alikasifoglu M; Tuncbilek E; Ayhan A
Int J Gynecol Cancer; 2006; 16(3):1407-11. PubMed ID: 16803538
[TBL] [Abstract][Full Text] [Related]
64. Quantitative assessment of the associations between CYP1A1 polymorphisms and gastric cancer risk.
Guo R; Guo X
Tumour Biol; 2012 Aug; 33(4):1125-32. PubMed ID: 22359202
[TBL] [Abstract][Full Text] [Related]
65. Common polymorphisms in the CYP1A1 and CYP11A1 genes and polycystic ovary syndrome risk: a meta-analysis and meta-regression.
Shen W; Li T; Hu Y; Liu H; Song M
Arch Gynecol Obstet; 2014 Jan; 289(1):107-18. PubMed ID: 23852617
[TBL] [Abstract][Full Text] [Related]
66. Combination effect of cytochrome P450 1A1 gene polymorphisms on uterine leiomyoma: A case-control study.
Salimi S; Sajadian M; Khodamian M; Yazdi A; Rezaee S; Mohammadpour-Gharehbagh A; Mokhtari M; Yaghmaie M
Bosn J Basic Med Sci; 2016 Aug; 16(3):209-14. PubMed ID: 27333216
[TBL] [Abstract][Full Text] [Related]
67. CYP1A1 Ile462Val is a risk factor for ovarian cancer development.
Huang M; Chen Q; Xiao J; Zhao X; Liu C
Cytokine; 2012 Apr; 58(1):73-8. PubMed ID: 22277800
[TBL] [Abstract][Full Text] [Related]
68. CYP1A1 Ile462Val polymorphism as a risk factor in cervical cancer development in the Polish population.
Roszak A; Lianeri M; Sowińska A; Jagodziński PP
Mol Diagn Ther; 2014 Aug; 18(4):445-50. PubMed ID: 24626963
[TBL] [Abstract][Full Text] [Related]
69. Effect of CYP1A1 MspI polymorphism on cigarette smoking related coronary artery disease and diabetes.
Wang XL; Greco M; Sim AS; Duarte N; Wang J; Wilcken DE
Atherosclerosis; 2002 Jun; 162(2):391-7. PubMed ID: 11996959
[TBL] [Abstract][Full Text] [Related]
70. Cytochrome P450 1A1 (CYP1A1) T3801C and A2455G polymorphisms in breast cancer risk: a meta-analysis.
Chen C; Huang Y; Li Y; Mao Y; Xie Y
J Hum Genet; 2007; 52(5):423. PubMed ID: 17427032
[TBL] [Abstract][Full Text] [Related]
71. Interleukin-4-receptor alpha gene polymorphism and the risk of renal cell carcinoma in a South Indian population.
Mohan S; Mohanasenthil ; Paul SF; Shroff S; Venkatesan V
Asian Pac J Cancer Prev; 2009; 10(2):295-8. PubMed ID: 19548368
[TBL] [Abstract][Full Text] [Related]
72. The interaction between smoking and CYP1A1 MspI polymorphism on lung cancer: a meta-analysis in the Chinese population.
Zhang LP; Wang CP; Li LH; Tang YF; Li WC
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26918783
[TBL] [Abstract][Full Text] [Related]
73. CYP1A1 polymorphism interactions with smoking status in oral cancer risk: evidence from epidemiological studies.
Yu KT; Ge C; Xu XF; Zou JC; Zou X; Zhen S
Tumour Biol; 2014 Nov; 35(11):11183-91. PubMed ID: 25106409
[TBL] [Abstract][Full Text] [Related]
74. CYP1A1 activity in renal cell carcinoma and in adjacent normal renal tissue.
Rintala S; Tammela TL; Tuimala R
Urol Res; 1998; 26(2):117-21. PubMed ID: 9631944
[TBL] [Abstract][Full Text] [Related]
75. Association between ACYP2 polymorphisms and the risk of renal cell cancer.
Wang Y; Zhang Y; Sun Y; Wu J; Chang J; Xiong Z; Niu F; Gu S; Jin T
Mol Genet Genomic Med; 2019 Nov; 7(11):e966. PubMed ID: 31487124
[TBL] [Abstract][Full Text] [Related]
76. [Association of cytochrome P450 gene MSP1 polymorphism and risk of preterm].
Jin Y; Chen DF; Yang F; Li ZP; Fang ZA; Li LS; Wang LH
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 36(6):595-9. PubMed ID: 15605089
[TBL] [Abstract][Full Text] [Related]
77. The Effect of the CYP1A1*2A Allele on Colorectal Cancer Susceptibility in a British Population.
Öztaş E; Özhan G; Daly AK
Genet Test Mol Biomarkers; 2016 Aug; 20(8):475-7. PubMed ID: 27243113
[TBL] [Abstract][Full Text] [Related]
78. Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead.
van Bemmel DM; Boffetta P; Liao LM; Berndt SI; Menashe I; Yeager M; Chanock S; Karami S; Zaridze D; Matteev V; Janout V; Kollarova H; Bencko V; Navratilova M; Szeszenia-Dabrowska N; Mates D; Slamova A; Rothman N; Han SS; Rosenberg PS; Brennan P; Chow WH; Moore LE
PLoS One; 2011; 6(7):e20432. PubMed ID: 21799727
[TBL] [Abstract][Full Text] [Related]
79. CYP1A1 MspI polymorphism and acute myeloid leukemia risk: meta-analyses based on 5018 subjects.
Zhuo W; Zhang L; Wang Y; Zhu B; Chen Z
J Exp Clin Cancer Res; 2012 Jul; 31(1):62. PubMed ID: 22846179
[TBL] [Abstract][Full Text] [Related]
80. Association between 3801T>C polymorphism of CYP1A1 and idiopathic male infertility risk: a systematic review and meta-analysis.
Luo H; Li H; Yao N; Hu L; He T
PLoS One; 2014; 9(1):e86649. PubMed ID: 24466186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
